These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33190170)

  • 1. Smarcd1 Inhibits the Malignant Phenotypes of Human Glioblastoma Cells via Crosstalk with Notch1.
    Zhu Y; Wang H; Fei M; Tang T; Niu W; Zhang L
    Mol Neurobiol; 2021 Apr; 58(4):1438-1452. PubMed ID: 33190170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
    Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B
    Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells.
    Lin J; Ji A; Qiu G; Feng H; Li J; Li S; Zou Y; Cui Y; Song C; He H; Lu Y
    Cancer Sci; 2018 Apr; 109(4):1001-1011. PubMed ID: 29427543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets.
    Cenciarelli C; Marei HE; Zonfrillo M; Casalbore P; Felsani A; Giannetti S; Trevisi G; Althani A; Mangiola A
    Oncotarget; 2017 Mar; 8(11):17873-17886. PubMed ID: 28157712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
    Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
    Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ORY-1001 inhibits glioblastoma cell growth by downregulating the Notch/HES1 pathway
    Yang H; Xiang Y; Tan T; Lei Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Aug; 44(8):1620-1630. PubMed ID: 39276059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference with PSMB4 Expression Exerts an Anti-Tumor Effect by Decreasing the Invasion and Proliferation of Human Glioblastoma Cells.
    Cheng YC; Tsai WC; Sung YC; Chang HH; Chen Y
    Cell Physiol Biochem; 2018; 45(2):819-831. PubMed ID: 29414809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
    Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Cyclin D1 Expression in Human Glioblastoma Cells is Associated with Increased Temozolomide Chemosensitivity.
    Zhang D; Dai D; Zhou M; Li Z; Wang C; Lu Y; Li Y; Wang J
    Cell Physiol Biochem; 2018; 51(6):2496-2508. PubMed ID: 30562739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis.
    Wang T; Mao P; Feng Y; Cui B; Zhang B; Chen C; Xu M; Gao K
    Cell Cycle; 2021 Jun; 20(12):1181-1194. PubMed ID: 34024251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of BCL6 Inhibited Malignant Phenotype and Enhanced Sensitivity of Glioblastoma Cells to TMZ through AKT Pathway.
    Song W; Wang Z; Kan P; Ma Z; Wang Y; Wu Q; Yao X; Zhang B
    Biomed Res Int; 2018; 2018():6953506. PubMed ID: 30420967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GASC1 promotes glioma progression by enhancing NOTCH1 signaling.
    Xiao Z; Yang X; Liu Z; Shao Z; Song C; Zhang K; Wang X; Li Z
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33649841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NCAPG2 facilitates glioblastoma cells' malignancy and xenograft tumor growth via HBO1 activation by phosphorylation.
    Wu J; Li L; Jiang G; Zhan H; Zhu X; Yang W
    Cell Tissue Res; 2021 Feb; 383(2):693-706. PubMed ID: 32897418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
    Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
    Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.
    Raghu H; Gondi CS; Dinh DH; Gujrati M; Rao JS
    Mol Cancer; 2011 Oct; 10():130. PubMed ID: 22004682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX3 can promote the malignant behavior of glioblastoma cells.
    Marjanovic Vicentic J; Drakulic D; Garcia I; Vukovic V; Aldaz P; Puskas N; Nikolic I; Tasic G; Raicevic S; Garros-Regulez L; Sampron N; Atkinson MJ; Anastasov N; Matheu A; Stevanovic M
    Cell Oncol (Dordr); 2019 Feb; 42(1):41-54. PubMed ID: 30209685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma.
    Huang S; Qi P; Zhang T; Li F; He X
    Oncol Rep; 2019 Mar; 41(3):1759-1768. PubMed ID: 30569180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNaseH2A is involved in human gliomagenesis through the regulation of cell proliferation and apoptosis.
    Dai B; Zhang P; Zhang Y; Pan C; Meng G; Xiao X; Wu Z; Jia W; Zhang J; Zhang L
    Oncol Rep; 2016 Jul; 36(1):173-80. PubMed ID: 27176716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of BMPR-IB reduces the malignancy of glioblastoma cells by upregulation of p21 and p27Kip1.
    Liu S; Yin F; Fan W; Wang S; Guo XR; Zhang JN; Tian ZM; Fan M
    J Exp Clin Cancer Res; 2012 May; 31(1):52. PubMed ID: 22650359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells.
    Zhang F; Liu R; Zhang H; Liu C; Liu C; Lu Y
    BMC Cancer; 2020 Jul; 20(1):673. PubMed ID: 32682409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.